290 related articles for article (PubMed ID: 12379707)
21. Targeting IL-27 and/or IL-10 in Experimental Murine Visceral Leishmaniasis.
Murray HW
Am J Trop Med Hyg; 2020 Nov; 103(5):1938-1941. PubMed ID: 32815498
[TBL] [Abstract][Full Text] [Related]
22. Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis.
Murray HW; Delph-Etienne S
Infect Immun; 2000 Jan; 68(1):288-93. PubMed ID: 10603400
[TBL] [Abstract][Full Text] [Related]
23. Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.
Murray HW; Xiang Z; Ma X
Am J Trop Med Hyg; 2006 Jun; 74(6):1013-5. PubMed ID: 16760512
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis.
Kole L; Das L; Das PK
J Infect Dis; 1999 Sep; 180(3):811-20. PubMed ID: 10438370
[TBL] [Abstract][Full Text] [Related]
25. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
26. Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice.
Taylor AP; Murray HW
J Exp Med; 1997 Apr; 185(7):1231-9. PubMed ID: 9104810
[TBL] [Abstract][Full Text] [Related]
27. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
28. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
Bhowmick S; Ravindran R; Ali N
Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
[TBL] [Abstract][Full Text] [Related]
29. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.
Murray HW; Nathan CF
J Exp Med; 1999 Feb; 189(4):741-6. PubMed ID: 9989990
[TBL] [Abstract][Full Text] [Related]
30. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
31. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
[TBL] [Abstract][Full Text] [Related]
32. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
Everlien H; Hockertz S
Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
[TBL] [Abstract][Full Text] [Related]
33. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
[TBL] [Abstract][Full Text] [Related]
34. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis.
Murray HW
J Infect Dis; 1997 Jun; 175(6):1477-9. PubMed ID: 9180189
[TBL] [Abstract][Full Text] [Related]
35. Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.
Murray HW; Luster AD; Zheng H; Ma X
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795366
[TBL] [Abstract][Full Text] [Related]
36. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
37. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
38. Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis.
Murray HW
J Immunol; 2005 Apr; 174(8):4916-23. PubMed ID: 15814719
[TBL] [Abstract][Full Text] [Related]
39. Antimony-Resistant Leishmania donovani Exploits miR-466i To Deactivate Host MyD88 for Regulating IL-10/IL-12 Levels during Early Hours of Infection.
Mukherjee B; Paul J; Mukherjee S; Mukhopadhyay R; Das S; Naskar K; Sundar S; Dujardin JC; Saha B; Roy S
J Immunol; 2015 Sep; 195(6):2731-42. PubMed ID: 26283478
[TBL] [Abstract][Full Text] [Related]
40. Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.
Murray HW; Mitchell-Flack M; Zheng H; Ma X
Infect Immun; 2015 Feb; 83(2):702-12. PubMed ID: 25452549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]